Enclomiphene Online in 2026: What It Really Costs and What You're Buying

The Short Answer

What Online Clinics Charge for Enclomiphene (October 2026)

We checked list prices on each clinic's own website on October 12, 2026. These are medication prices. Where a clinic publishes its lab fee we show it; most don't put one on the enclomiphene page.

Sources: TRT Nation's enclomiphene page and FAQ, Maximus's enclomiphene page, and Hims's testosterone page.

The headline numbers cluster around $100, but the terms behind them differ. Maximus gets to $99.99 only on its 12-month plan. Hims's $99 assumes you pay for 10 months at once, which works out to $990 upfront (the page doesn't say whether the initial at-home lab kit is included). TRT Nation lists $99.99 for a 30-day supply and states no minimum on its enclomiphene page, though its cancellation policy mentions a 2.5-month period, so ask whether it applies to you. Confirm the terms at checkout, as you should with any clinic.

For a fuller picture of each provider, see our TRT Nation review, Maximus review and Hims review.

Enclomiphene isn't automatically cheaper than TRT

It's easy to assume a daily pill costs less than injections. At these list prices it doesn't. TRT Nation charges the same $99.99 a month for testosterone as for enclomiphene, and BiltRx lists testosterone injections at $65 a month. BiltRx says its medications are compounded by 503A pharmacies "when appropriate", and its FAQ lists a required $9.99 monthly membership and says consultation and medication costs are billed separately. Lab fees aren't published, so ask before paying.

If cost is your main concern, also ask about generic clomiphene, the older drug enclomiphene is isolated from. We compare the two in clomiphene vs. enclomiphene.

What You're Buying: A Compounded Drug Without FDA Approval

No enclomiphene product has FDA approval. Repros Therapeutics filed a new drug application, and in late 2015 FDA issued a complete response letter saying the Phase 3 design was "no longer adequate to demonstrate clinical benefit" and raising concerns about entry criteria, titration and bioanalytical method validation, as BioSpace reported at the time.

Europe said no too. The European Medicines Agency refused authorization for enclomiphene (as EnCyzix) in April 2018, concluding that its benefits did not outweigh its risks. The agency noted the studies didn't test whether symptoms improved and flagged a risk of venous thromboembolism, meaning blood clots in the veins.

The enclomiphene sold online is therefore made by compounding pharmacies. FDA's own wording applies: compounded drugs are not FDA-approved, so FDA does not verify their safety, effectiveness or quality before they're sold.

Where enclomiphene stands with FDA as of October 2026

FDA keeps a list of bulk drug substances nominated for use by 503A (state-licensed) compounding pharmacies. On the current version of that list, updated May 14, 2026, enclomiphene citrate is in Category 1, "Bulk Drug Substances Under Evaluation."

Category 1 matters because of how FDA treats it. According to FDA's 503A bulk substances page, the agency does not intend to take action against pharmacies compounding with Category 1 substances, provided the other conditions in its guidance are met. That holds until FDA decides whether the substance goes on the official 503A bulks list, or removes it from Category 1 (for example, over safety concerns).

That's a holding pattern, not an endorsement. At a June 2022 advisory committee meeting, FDA proposed that enclomiphene citrate not be added to the 503A bulks list, and the committee voted 8 to 4 in agreement. FDA's briefing document concluded there was "insufficient information to support the effectiveness" of enclomiphene for the proposed use, noting that serum testosterone is not a validated surrogate endpoint. The category list can change, so check the date on any clinic's regulatory claims.

Labs and Monitoring: The Cost on Top of the Pill

Enclomiphene is a prescription drug, so expect bloodwork before you start and again during treatment. The AUA guideline says a low-testosterone diagnosis should rest on two early-morning total testosterone measurements on separate occasions, and it treats 300 ng/dL as a reasonable cutoff.

Enclomiphene works by raising LH and FSH, the pituitary hormones that drive the testes. Ask whether your panel includes them, because they help show whether your low T comes from signaling or from the testes themselves. Our guide to secondary vs. primary hypogonadism explains why that matters here.

FDA's 2022 review listed elevated estradiol, increased PSA and increased hematocrit among its safety concerns. It also noted that the EMA recommended ocular safety monitoring after cataracts appeared in a dog toxicology study. Ask your prescriber how they plan to watch for each of these.

What those labs cost

• TRT Nation: a $129 lab fee listed on its testosterone page (the enclomiphene page shows no lab price), or your own labs if they're no more than 6 months old. Its listed panel is total testosterone, CBC, CMP, sensitive estradiol, and PSA for patients over 40.
• Self-ordered retail tests: Quest's consumer site lists a total testosterone test at $69 plus a $6 physician service fee, and a PSA test at $69. Quest adds a physician service fee that starts at $6.
• Maximus and Hims: lab prices weren't published on the pages we checked. Ask for the number before you pay.

Here's what a first year looks like at TRT Nation's list prices. It's simple arithmetic, not a quote.

How often you retest is your prescriber's call. Ask before you sign up. If you already have recent bloodwork, see which clinics accept outside labs.

Who Enclomiphene Suits, and Who It Doesn't

Enclomiphene is a selective estrogen receptor modulator (SERM). FDA's review describes it as blocking estrogen's suppression of the hypothalamic-pituitary-gonadal axis, so the pituitary releases more LH and FSH and the testes make more testosterone. FDA evaluated it for compounding in secondary hypogonadism, the condition its clinical trials studied.

Reasonable fits

• Men with secondary hypogonadism who want to avoid suppressing sperm production. In two 16-week Phase 3 trials, enclomiphene raised total testosterone, LH and FSH and kept sperm concentration in the normal range, while testosterone gel markedly reduced sperm production (Kim et al., BJU International). Those trials measured sperm concentration, not conception; FDA noted they did not assess fertility outcomes. The AUA says testosterone therapy should not be prescribed to men currently trying to conceive, and it lists SERMs among the options for men who want to maintain fertility (a conditional recommendation on grade C evidence).
• Men who won't do injections and accept the evidence gaps below.

Poor fits

• Primary hypogonadism. Enclomiphene works through the testes' response to LH, and it was studied, and evaluated by FDA for compounding, in secondary hypogonadism.
• A history of blood clots. The EMA cited a risk of venous thromboembolism, and FDA's review quotes the EMA's count of four thromboembolic events in the development program, one of them fatal. Raise any clotting history with the prescriber.
• Drug-tested athletes. Clomiphene is on the WADA Prohibited List, and enclomiphene falls under the same section, per Operation Supplement Safety.
• Anyone expecting proven symptom relief. The trials measured hormone levels. FDA and the EMA both noted they didn't assess whether symptoms improved.

For the full comparison with testosterone therapy, see enclomiphene as a fertility-preserving alternative.

Questions to Ask Before You Pay

1. What's my total for the first three months? Medication, labs, consult and shipping, as one number.
2. Is there a minimum term or upfront charge? Two of the three lowest advertised prices above require a long plan or upfront payment, and TRT Nation's cancellation policy refers to a 2.5-month period.
3. Which pharmacy compounds it? Get the pharmacy's name and confirm it's a state-licensed 503A pharmacy. Our compounded vs. pharmaceutical comparison explains what that does and doesn't guarantee.
4. What strength, and who adjusts it? Per FDA's review, the Phase 3 trials tested 12.5 mg and 25 mg strengths. TRT Nation's listing is 25 mg capsules. Your prescriber sets the dose.
5. Which labs, how often, and will you accept mine?
6. What happens if my numbers don't move? Ask whether the same clinic can switch you to testosterone therapy, and what that would cost.

Still weighing options? Use our clinic comparison, or run a year's numbers through the cost calculator.

The Bottom Line

Budget about $100 a month for enclomiphene at the lower online prices, more if you want month-to-month flexibility, and add labs on top. TRT Nation lists $129 for its testosterone panel, and a single self-ordered testosterone test at Quest runs $75 with fees. Read the plan terms, because the lowest advertised prices often come with a 10- or 12-month commitment.

Go in clear-eyed about the regulatory side. As of October 2026, enclomiphene is compounded, not FDA-approved, and FDA's tolerance of compounding it is provisional. It makes the most sense for men with secondary hypogonadism who want to preserve fertility. It makes less sense if cost is your main concern, since testosterone itself costs the same or less at the clinics mentioned above. Take the questions above to your consult and let the prescriber's read of your labs decide.